Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2008
10/14/2008CA2190394C Recombinant viruses, preparation and use thereof in gene therapy
10/09/2008WO2008121963A2 Compositions and methods for gene silencing
10/09/2008WO2008121442A2 Pa28-gamma regulation in cells
10/09/2008WO2008121385A2 Compositions and methods useful for modulating spondyloarthropathies
10/09/2008WO2008121125A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
10/09/2008WO2008121016A1 Oncological disease treating method
10/09/2008WO2008121007A1 Novel saratan polypeptides and polynucleotides and methods of use thereof
10/09/2008WO2008120815A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008WO2008120736A1 Transpulmonary liposome for controlling drug arrival
10/09/2008WO2008119827A1 Transreplicase constructs
10/09/2008WO2008119258A1 A recombinant adenovirus useful for treating malignancy overexpressing proto-oncogene neu/erbb2
10/09/2008WO2008045486A3 Nanoparticle compositions for controlled delivery of nucleic acids
10/09/2008WO2007126798A3 Regulated expression of recombinant proteins from adeno-associated viral vectors
10/09/2008WO2007123737A3 Methods and compositions for localized secretion of anti-ctla-4 antibodies
10/09/2008WO2007089805A3 Anti-hypertrophic effects and inotropic effects of picot
10/09/2008WO2007084740A3 Tat-030 and methods of assessing and treating cancer
10/09/2008US20080250517 Methods
10/09/2008US20080249294 RNA Interference Mediated Inhibition of Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/09/2008US20080249050 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome
10/09/2008US20080249049 for the delivery of nucleic acid to target cells or tissues; poly(amino acid), polysaccharide, polyester, polyether, polyurethane or vinyl polymer
10/09/2008US20080249047 Modulation of Inflammation Through Modulation of Elavl1/HuR Expression
10/09/2008US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
10/09/2008US20080249025 Peptide fragments of p21; antiproliferative agents
10/09/2008US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions
10/09/2008US20080249008 Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor
10/09/2008US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
10/09/2008US20080248544 Methods And Compositions For Grafting Functional Loops Into A Protein
10/09/2008US20080248528 Erythrovirus and its applications
10/09/2008US20080248099 using insulin for making medicine to treat Alzheimer's disease, brain atrophy associated with diabetes, Parkinson's disease, Huntington's Disease, senile dementia, multiple sclerosis, dementia associated with Acquired Immunodeficiency Syndrome (AIDS), Pick's Disease, stroke, trauma; tolbutamide
10/09/2008US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248010 Protein kinase for use as tool in identifying modulators for treatment of diabetes
10/09/2008US20080248009 Using antisense agents specific to apoptosis-associated nucleic acids to modulate apoptosis in transplanted tissues; treating cell proliferative disorders
10/09/2008US20080248002 Cytokine induced killer cell populations for use in treatment of cell proliferative disordersl; tissue engineering and repair; tissue targeted therapy
10/09/2008US20080247996 Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation
10/09/2008US20080247995 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
10/09/2008US20080247994 DNA vaccine
10/09/2008US20080247956 Identification of novel factors that block programmed cell death or apoptosis by targeting jnk
10/09/2008US20080247625 Method and System for Leading Macromolecule Substances into Living Target Cells
10/09/2008CA2682493A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008CA2682376A1 Transpulmonary liposome for controlling drug arrival
10/09/2008CA2682155A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same
10/08/2008EP1978090A1 Pancreatic progenitor cells
10/08/2008EP1978031A2 Tropoelastin derivatives
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1977767A1 Method for in vivo regulation of cardiac muscle contractility
10/08/2008EP1977764A1 Formulation of adenovirus for gene therapy
10/08/2008EP1977246A1 Na+, k+-atpase expression in cervical dysplasia and cancer
10/08/2008EP1976870A1 Prevention/treatment of ichthyosis vulgaris, atopy and other disorders
10/08/2008EP1976547A1 R-ras activity in vascular regulation
10/08/2008EP1611247B1 Cyp2s1 as target for diagnosis and therapy of skin diseases
10/08/2008EP1507795B1 Tumour-associated peptides that bond to mhc molecules
10/08/2008EP1485346B1 Novel positively charged lipids and liposomes comprising the positively charged lipids
10/08/2008EP1465521A4 System and method for the pretreatment of the endplates of an intervertebral disc
10/08/2008EP1390059B1 Improved neuronal gene transfer
10/08/2008EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer
10/08/2008EP1189626B1 Composition for preventing tumoral growth
10/08/2008EP1157105B8 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
10/08/2008EP1141334B1 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101280318A Recombinant human HNP gene liposome complex, preparation and use thereof
10/08/2008CN101280317A FAK and EGFR targeted RNA interference plasmid-lipidosome antineoplastic complex
10/08/2008CN101280316A Therapeutic vaccine for human cervical carcinoma
10/08/2008CN101280293A Urate oxidase
10/08/2008CN101279097A Gene immunity method
10/08/2008CN100424182C Methods for detecting and treating the early onset of aging-related conditions
10/08/2008CN100424175C Methods and compositions for treating neoplasms by ERBB3
10/08/2008CN100423781C Application of Resistin binding polypeptide for preparing medicine promoting insulin secretion
10/07/2008US7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof
10/07/2008US7432363 Ly6H gene
10/07/2008US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
10/07/2008US7432358 Oncogene, recombinant protein derived therefrom, and uses thereof
10/07/2008US7432344 Porcine CTLA-4 for xenograft-specific immunosuppression
10/07/2008US7432250 Oligoribonucleotides and ribonucleases for cleaving RNA
10/07/2008US7432249 Oligoribonucleotides and ribonucleases for cleaving RNA
10/07/2008US7432237 Methods of treating asthma by administering interleukin-17 receptor
10/07/2008US7432077 High-affinity choline transporter
10/07/2008US7432067 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility
10/07/2008US7432065 Microarray for identifying regulator peptides which bind and regulate modular protein domain (PDZ) interactions with hematopoietic cells for use in treatment of autoimmune, cell proliferative and nervous system disorders; peptide mimetics
10/07/2008US7432059 Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal
10/07/2008US7432050 Methods and compositions for detecting colon cancers
10/07/2008US7432047 Method for selective inactivation of viral replication
10/07/2008US7431932 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition; reducing the risk of introducing or reintroducing neoplastic cells into the recipient
10/07/2008US7431922 Bioadhesive directed somatic cell therapy
10/07/2008CA2296067C Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
10/07/2008CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof
10/02/2008WO2008119000A1 Zinc-finger nuclease and rna interference mediated inactivation of viral genomes
10/02/2008WO2008118970A2 Constructs and libraries comprising antibody surrogate light chain sequences
10/02/2008WO2008118936A2 Method of elicting immune response with a modified mva viral hiv-1 vector
10/02/2008WO2008118507A2 Recombinant human factor ix and use thereof
10/02/2008WO2008118350A1 Compositions and methods of using crmp-1 and its fragments for treating cancer
10/02/2008WO2008118212A2 In vivo delivery of double stranded rna to a target cell
10/02/2008WO2008117971A1 Use of inhibitors of leukotriene b4 receptor blt2 for treating asthma
10/02/2008WO2008117970A1 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers
10/02/2008WO2008117828A1 Prompt nucleic acid delivery carrier composition
10/02/2008WO2008117523A1 Antiviral agent
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 870